Avantor, Inc. (AVTR) Covered Calls
Avantor, Inc. is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education, government, and advanced technologies industries. The company offers a vast portfolio ranging from high-purity chemicals and reagents to lab equipment and specialized workflows. By supporting customers from discovery to delivery, it plays an essential role in the research, development, and production activities of the life sciences sector worldwide.
You can sell covered calls on Avantor, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AVTR (prices last updated Wed 4:16 PM ET):
| Avantor, Inc. (AVTR) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 8.28 | -0.25 | 8.07 | 8.39 | 9.2M | - | 5.8 |
| Covered Calls For Avantor, Inc. (AVTR) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| May 15 | 8 | 0.75 | 7.64 | 4.7% | 71.5% | |
| Jun 18 | 8 | 0.75 | 7.64 | 4.7% | 29.6% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Avantor, Inc. serves as a vital partner to the global scientific community, providing the materials and services necessary for breakthroughs in medicine and technology. The company operates through two primary segments: Laboratory Solutions and Bioscience Production. It provides an extensive range of products, including ultra-high-purity chemicals, specialized excipients, and single-use systems used in the manufacturing of biologics and other advanced therapies.
The firm maintains an expansive distribution network that reaches over three hundred thousand customer locations across nearly two hundred countries. Its business model integrates proprietary manufacturing with a third-party product platform, offering a comprehensive supply chain solution for research labs and large-scale production facilities. This deep integration into customer workflows makes the company a foundational element of the life sciences ecosystem, ensuring the reliability of complex scientific processes.
Competitive Landscape
The life sciences tools and services industry is highly competitive, consisting of large diversified providers and specialized equipment manufacturers. The company competes on the basis of its broad product portfolio, global distribution capabilities, and technical expertise. It faces competition from other major entities that provide lab supplies and production materials to the biopharma and healthcare sectors.
- Thermo Fisher Scientific: A primary competitor and global leader in providing scientific instrumentation, reagents, and clinical services.
- Agilent Technologies: A key rival focusing on analytical laboratory technologies and clinical research tools.
- Revvity: A global provider of health science solutions that competes in the diagnostics and life sciences research markets.
- Danaher Corporation: A significant competitor through its life sciences and biotechnology segments, offering advanced tools for biopharmaceutical production.
- Repligen: A specialized competitor focusing on bioprocessing technologies used in the manufacturing of biological drugs.
Strategic Outlook and Innovation
The strategic focus of the organization is centered on expanding its presence in the high-growth bioproduction market. By investing in single-use technologies and customized purification solutions, the company aims to support the rapid development of cell and gene therapies. This shift towards more specialized and proprietary products is intended to enhance margins and provide more unique value to long-term partners in the pharmaceutical industry.
Innovation at the company is driven by the need for greater efficiency and sustainability in the lab. This includes the development of environmentally friendly packaging systems and digital tools that optimize inventory management for customers. By leveraging data analytics to streamline the procurement process, the firm seeks to reduce lead times and improve the reliability of critical supplies. These initiatives are designed to reinforce its position as a preferred partner for global scientific innovation.
| Top 10 Open Interest For May 15 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | SLV covered calls | 6. | TLT covered calls | 1. | NOW covered calls | |
| 2. | NVDA covered calls | 7. | HYG covered calls | 2. | QS covered calls | |
| 3. | IBIT covered calls | 8. | QQQ covered calls | 3. | POET covered calls | |
| 4. | GLD covered calls | 9. | KWEB covered calls | 4. | NOK covered calls | |
| 5. | SPY covered calls | 10. | EEM covered calls | 5. | TLRY covered calls | |
Want more examples? AVT Covered Calls | AVUS Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
